» Articles » PMID: 24095820

Novel MNX1 Mutations and Clinical Analysis of Familial and Sporadic Currarino Cases

Overview
Journal Eur J Med Genet
Publisher Elsevier
Specialty Genetics
Date 2013 Oct 8
PMID 24095820
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Currarino Syndrome (CS) is a rare congenital malformation characterized by three major clinical aspects: sacral anomalies, anorectal malformation and presacral mass. In familial settings the disorder is transmitted as autosomal dominant trait, with a wide phenotype variability and low penetrance. The causative gene of CS is the motor neuron and pancreas homeobox-1 (MNX1), mapped at 7q36, and coding for a transcription factor. Mutations in the MNX1 have been implicated in almost all familial but only in 30% of sporadic cases. In our cohort of 28 CS cases, 8 were familiar, 18 were sporadic and 2 were not determined cases. We performed mutational analysis of MNX1 in all cases by DNA sequencing as well as by Multiplex Ligation-dependent Probe Amplification (MLPA) in those CS cases where no MNX1 mutations were found, to exclude a MNX1 heterozygous loss. We identified 10 novel and 4 recurrent mutations. Among the novel mutations, 2 were frameshift variants (p.Ser4IlefsX52, p.Phe248SerfsX35), 6 were missense variants (p.Pro27Leu, p.Gly103Arg, p.Leu254Pro, p.Leu278Pro, p.Glu282Lys, p.Arg292Gly), one was a non-sense variant (p.Lys297X), and the last one was a synonymous variant (p.Gln290Gln). Mutated patients showed a variability of phenotypes but all share at least the association of sacral agenesis and presacral mass, and this co-occurrence can constitute a pathognomonic sign to perform MNX1 analysis. Genetic heterogeneity could be a possible explanation for some of the sporadic not mutated patients even if a mis-diagnosis could not be excluded. Finally, we provide an up-date of the more recent literature, reporting a total number of 82 MNX1-CS related mutations.

Citing Articles

MNX1 facilitates the malignant progress of lung adenocarcinoma through transcriptionally upregulating CCDC34.

Wu J, Yue C, Xu W, Li H, Zhu J, Li L Oncol Lett. 2023; 26(2):325.

PMID: 37415626 PMC: 10320431. DOI: 10.3892/ol.2023.13911.


Characterization of complete Currarino syndrome in pediatrics-a comparison between CT and MRI.

Chen J, Zheng N, Wang C, Shao J, Qi X, Xie Y Ann Transl Med. 2022; 10(2):63.

PMID: 35282111 PMC: 8848446. DOI: 10.21037/atm-21-6572.


Currarino syndrome: a comprehensive genetic review of a rare congenital disorder.

Dworschak G, Reutter H, Ludwig M Orphanet J Rare Dis. 2021; 16(1):167.

PMID: 33836786 PMC: 8034116. DOI: 10.1186/s13023-021-01799-0.


Currarino syndrome in an elderly man: Multimodality imaging findings.

Vitale A, Villa R, Giordano F, Napoli E, Ugga L, Manto A Radiol Case Rep. 2020; 15(10):1858-1863.

PMID: 32817777 PMC: 7426326. DOI: 10.1016/j.radcr.2020.07.049.


Novel MNX1 mutations and genotype-phenotype analysis of patients with Currarino syndrome.

Han L, Zhang Z, Wang H, Song H, Gao Q, Yan Y Orphanet J Rare Dis. 2020; 15(1):155.

PMID: 32571425 PMC: 7310025. DOI: 10.1186/s13023-020-01442-4.